Contact us here

Consortium partners

The PIONEER consortium was established in January 2018 and will run for a period of 5 years. We are determined to empower meaningful improvement, through the utilisation of Big Data technologies in: clinical practice; prostate cancer disease-related outcomes both clinical- and patient-specific; and health-economic outcomes across the European healthcare landscape.

PIONEER brings together 32 key stakeholders in prostate cancer research and clinical care from across 9 countries. Consortium members are drawn from academic institutions, European organisations, patient advocacy groups, clinicians, and pharmaceutical companies, as well as regulatory agencies, experts in legal data management, economics and ethics, and information and technology specialists.

Coordinator (EAU) & Co-Coordinators

Leader (Bayer) & Co-Leads